How to perform diagnostic and prognostic analysis of hypertrophic cardiomyopathy in 2022: should we divide to improve treatment? hipertrófica: 2022.

HIGHLIGHTS

  • who: Cardiomiopatia Hipertru00f3fica Como Realizar et al. from the Luz Hospital have published the research work: How to Perform Diagnostic and Prognostic Analysis of Hypertrophic Cardiomyopathy in 2022: Should we Divide to Improve Treatment? Hipertru00f3fica: 2022., in the Journal: (JOURNAL)

SUMMARY

    Mailing Address: Alexandra Toste. to being a cause of sudden death in young adults and athletes.6 HCM can progress according to several profiles: heart failure (HF) with preserved ejection fraction due to diastolic dysfunction and/or obstruction; HF with reduced ejection fraction; atrial fibrillation (AF) and stroke; ventricular arrhythmias; and sudden . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?